Certifications will be an increasingly important part of the future sports nutrition marketplace, says PLT Health Solutions as it announces a new verification of one of its new ingredients.
FrieslandCampina Ingredients has announced the launch of Biotis - a new range of health benefit solutions aimed at supporting health and wellness throughout all life stages.
The Natural Products Association (NPA) is calling for the US Food and Drug Administration to use import alerts to stop nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations.
The coronavirus crisis is placing huge demands on American workers. For a company like Balchem, which is seeing surging demand for some of its nutritional products like zinc, employee motivation is being helped by seeing how important their work is, says...
Chia supplier Benexia has secured its supply chain to keep producing during the global pandemic, and the company says the inflammation fighting properties of its products has seen demand rise.
Blis Technologies Limited and distributor Stratum Nutrition announced the publication of two recent studies that investigated the effectiveness of BLIS M18 on black teeth staining.
The Federal Trade Commission has sent out another round of warning letters to 50 more marketers nationwide, most of which are labeled as dietary supplements or Chinese herbs.
Plant cell culture is an inviting technology to produce bioactives from certain botanicals. The approach is a difficult one to master, however, which is a primary reason why it is still somewhat rare in the market.
Supplementation with a standardized oil from black cumin (Nigella sativa) may significantly reduce blood pressure, suggests data from a small non-randomized clinical trial.
UK-based microbiome firm Eagle Genomics is to enter into a pact with Cargill as part of a multi-year deal looking to harness artificial intelligence (AI) to the agricultural commodity giant’s microbiome and life sciences R&D.
The boom in hemp cultivation after the passage of the 2018 Farm Bill has created a supply bulge that the industry is still working through, observers say.
New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’
The regulatory issues that continue to cloud the CBD market have made room for alternative modes to affect the endocannabinoid system. Bolstered by recent bioavailability research, Gencor Pacifc thinks its Levagen PEA ingredient could be a winner.
